Pfizer Responds to Research Claims
Pfizer
JANUARY 27, 2023
This research provides a way for us to rapidly assess the ability of an existing vaccine to induce antibodies that neutralize a newly identified variant of concern. and global regulatory requirements for our oral treatment, PAXLOVIDâ„¢, Pfizer undertakes in vitro work (e.g., In addition, to meet U.S. and around the world.
Let's personalize your content